Development of a QSAR model for binding of tripeptides and tripeptidomimetics to the human intestinal di-/tripeptide transporter hPEPT1
- PMID: 16489544
- DOI: 10.1007/s11095-006-9462-y
Development of a QSAR model for binding of tripeptides and tripeptidomimetics to the human intestinal di-/tripeptide transporter hPEPT1
Abstract
Purpose: The aim of this study was to develop a three-dimensional quantitative structure-activity relationship (QSAR) model for binding of tripeptides and tripeptidomimetics to hPEPT1 based on a series of 25 diverse tripeptides.
Methods: VolSurf descriptors were generated and correlated with binding affinities by multivariate data analysis. The affinities for hPEPT1 of the tripeptides and tripeptidomimetics were determined experimentally by use of Caco-2 cell monolayers.
Results: The Ki-values of the 25 tripeptides and tripeptidomimetics ranged from 0.15 to 25 mM and the structural diversity of the compounds was described by VolSurf descriptors. A QSAR model that correlated the VolSurf descriptors of the tripeptides with their experimental binding affinity for hPEPT1 was established.
Conclusion: Structural information on tripeptide properties influencing the binding to hPEPT1 was extracted from the QSAR model. This information may contribute to the drug design process of tripeptides and tripeptidomimetics where hPEPT1 is targeted as an absorptive transporter for improvement of intestinal absorption. To our knowledge, this is the first time a correlation between VolSurf descriptors and binding affinities for hPEPT1 has been reported.
Similar articles
-
A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1).AAPS J. 2010 Sep;12(3):385-96. doi: 10.1208/s12248-010-9195-z. Epub 2010 May 8. AAPS J. 2010. PMID: 20449699 Free PMC article.
-
In vitro evaluation of N-methyl amide tripeptidomimetics as substrates for the human intestinal di-/tri-peptide transporter hPEPT1.Eur J Pharm Sci. 2006 Jul;28(4):325-35. doi: 10.1016/j.ejps.2006.03.007. Epub 2006 Mar 28. Eur J Pharm Sci. 2006. PMID: 16713701
-
Design, synthesis, and evaluation of tripeptidic promoieties targeting the intestinal peptide transporter hPEPT1.ChemMedChem. 2007 Apr;2(4):479-87. doi: 10.1002/cmdc.200600200. ChemMedChem. 2007. PMID: 17407174
-
Recent advances in structural biology of peptide transporters.Curr Top Membr. 2012;70:257-74. doi: 10.1016/B978-0-12-394316-3.00008-9. Curr Top Membr. 2012. PMID: 23177989 Review.
-
The oligopeptide transporter hPepT1: gateway to the innate immune response.Lab Invest. 2006 Jun;86(6):538-46. doi: 10.1038/labinvest.3700423. Lab Invest. 2006. PMID: 16652110 Review.
Cited by
-
Bioavailability through PepT1: the role of computer modelling in intelligent drug design.Curr Comput Aided Drug Des. 2010 Mar;6(1):68-78. doi: 10.2174/157340910790980133. Curr Comput Aided Drug Des. 2010. PMID: 20370696 Free PMC article. Review.
-
A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1).AAPS J. 2010 Sep;12(3):385-96. doi: 10.1208/s12248-010-9195-z. Epub 2010 May 8. AAPS J. 2010. PMID: 20449699 Free PMC article.
-
Modeling kinetics of subcellular disposition of chemicals.Chem Rev. 2009 May;109(5):1793-899. doi: 10.1021/cr030440j. Chem Rev. 2009. PMID: 19265398 Free PMC article. Review. No abstract available.
-
The tandem chain extension aldol reaction used for synthesis of ketomethylene tripeptidomimetics targeting hPEPT1.Bioorg Med Chem Lett. 2011 Aug 1;21(15):4597-601. doi: 10.1016/j.bmcl.2011.05.108. Epub 2011 Jun 6. Bioorg Med Chem Lett. 2011. PMID: 21703856 Free PMC article.
-
Artificial neural network models for prediction of intestinal permeability of oligopeptides.BMC Bioinformatics. 2007 Jul 11;8:245. doi: 10.1186/1471-2105-8-245. BMC Bioinformatics. 2007. PMID: 17623108 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources